/ 2. Caspase-3/7/ calcein-m/ethd-1 DTS DTS 1C annexin V/ PI 1DDR5 DR4 DTS DR5 DR4 9 DTS z-vd-fmk caspase-8 z-ietdfmkcaspase-9 z-lehd-

Size: px
Start display at page:

Download "/ 2. Caspase-3/7/ calcein-m/ethd-1 DTS DTS 1C annexin V/ PI 1DDR5 DR4 DTS DR5 DR4 9 DTS z-vd-fmk caspase-8 z-ietdfmkcaspase-9 z-lehd-"

Transcription

1 Vol pp / 1 1, /diallyltrisulfide-induced apoptosis in human melanoma cells Yoshihiro SUZUKI 1 Mayumi MURI 1,2 Shigeru NISHID 3 Miki SUZUKI-KRSKI 2 Chisei R 1 Toyoko OCHII 2 Tumor necrosis factor (TNF)-related apoptosis-inducing ligand TNF DTS DTS 1. Tumor necrosis factor TNF -related apoptosis-inducing ligand TNF death receptor DR 4/ receptor -R 1 DR5/-R2 -R3- R4 1,2 DR4 DR5 death domain -R3 - R4 3 extrinsic pathway intrin- sic pathway 1-3 DTS 4-7 DTS DTS suzuki.yoshihro@nihon-u.ac.jp 64

2 / 2. Caspase-3/7/ calcein-m/ethd-1 DTS DTS 1C annexin V/ PI 1DDR5 DR4 DTS DR5 DR4 9 DTS z-vd-fmk caspase-8 z-ietdfmkcaspase-9 z-lehd- 375 cells 258 cells 図 1 Vehicle (25ng/ml) DTS (1 M) + DTS C Melanocytes D poptotic cells % Vehicle DTS 1 M 25ng/ml +DTS 1 -C C 825 ng/ml 1 M DTS 24 calcein-m Ethd-1 calcein-m Ethd-1 Scale bar = 1 m. (D) /well V/PI FCSCalibur CellQuest V n=3-9, p<.1; p<.1. 65

3 fmk75 caspase-3/7 z-devd-fmk 5 9 m caspase-3/7 m caspase-3/7 25 ng/ml 72 DTS m caspase-3/7 9 DR4 caspase-3/7 m DR5 caspase-3/7 m DTS caspase-3/7 m DR4 DR5 caspase-3/7 m 9 caspase-3/ ng/mldr5 caspase-3/7 DTS caspase-3/7 DR5 capsase-3/7 9 DTS unfolded protein response UPR GRP78 XP1 DR5 XP-1 DTS GRP78 XP-1 2DR4 DTS 2 Tg GRP78 XP DTS caspase-12 z-td-fmk caspase-4 z- LEVD-fmk 2caspase-12 3 DTS 3 DR5 caspase-12 DTS DR4 caspase-12 DTS DTS caspase caspase-12 DR5 caspase-12 DTS DR4 DTS caspase-12 9 DTS (1 M) GRP78 XP-1 -actin poptotic cells % Inhibitor (1 M) (25 ng/ml) DTS (1 M) C3/7 C12 C4 C ll 図 2 XP-1s XP-1u 2 () / well 1 g/ml DR5/DR4 1 M DTS 3724 SDS PVDF PVDF GRP78 XP-1 PVDF -actin () M z-devd-fmk; C3/7 z-td-fmk C12z-LEVD-fmk C4 z-vd-fmk C ll 25ng/ml 1 M DTS 3772 V/PI FCSCalibur CellQuest V- n=3, p<.1. 66

4 / Caspase-12-activated cells % Caspase-12-activated cells % (1 ng/ml) - DTS (1 M) - (ng/ml) 24 h * Melanocytes 24 h 4. DTS DR 1 DTS 11 DTS DTS 4-7, M * () ng/ml Caspase-12 CaspGLOW Fluorescein Caspase-12 Staining Kit FCSCalibur CellQuest n=3, *p<.5, p<.1, p<.1 () D,E /well1 ng/ ml 1 M DTS Caspase-12 CaspGLOW Fluorescein Caspase-12 Staining Kit FCSCalibur CellQuest n= 3, *p<.5, p<.1. DTS 24 5 M 1 M DTS 24 < 2 DTS DTS 4-7 DTS 13 intrinsic pathway DTS intrinsic pathway caspase-9 caspase-3/7 DTS caspase-3/7 intrinsic pathway intrinsic pathway extrinsic pathway intrinsic pathway IRE TF6 Perk GRP78/ip UPR UPR 18,19 XP-1 DR5 2 XP-1 DTS caspase DTS 67

5 5. DTS DTS 1 Yerbes R, Palacios C, Lopez-Rivas. The therapeutic potential of receptor signaling in cancer cells. Clin Transl Oncol 211; 13: Wang S. The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and receptor pathway. Oncogene 28; 27: Lelanc, HN, shkenazi. po2l/ and its death and decoy receptors. Cell Death Differ 23; 1: Das, anik NL, Ray SK. Garlic compounds generate reactive oxygen species leading to activation of stress kinases and cysteine proteases for apoptosis in human glioblastoma T98G and U87MG cells. Cancer 27; 11: Kim Y, Xiao D, Xiao H et al. Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by ax/ak. Mol Cancer Ther 27; 6: Xiao D, Choi S, Johnson DE et al. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-jun N-terminal kinase and extracellularsignal regulated kinase-mediated phosphorylation of cl-2. Oncogene 24; 22: usch C, Jacob C, nwar et al. Diallylpolysulfides induce growth arrest and apoptosis. Int J Oncol 21; 36: Suzuki Y, Inoue T, Murai M et al. Depolarization potentiates -induced apoptosis in human melanoma cells: Role for TP-sensitive K+ channels and endoplasmic reticulum stress. Int J Oncol 212; 41: Murai M, Inoue T, Suzuki-Karasaki M et al. Diallyl trisulfide sensitizes human melanoma cells to induced cell death by promoting endoplasmic reticulum-mediated apoptosis. Int J Oncol 212; 41: shkenazi, Pai R, Fong S et al. Safety and antitumor activity of recombinant soluble po2 ligand. J Clin Invest 1999; 14: Powlny, Singh SV. Multitargeted prevention and therapy of cancer by diallyl trisulfide and related llium vegetable-derived organosulfur compounds. Cancer Lett 28; 269: Lee C, Park H, Kim SY et al. Role of im in diallyl trisulfide-induced cytotoxicity in human cancer cells. J Cell iochem 211; 112: Shankar S, Chen Q, Ganapathy S et al. Diallyl trisulfide increases the effectiveness of and inhibits prostate cancer growth in an orthotropic model: molecular mechanisms. Mol Cancer Ther 28; 7: alch CM, uzzaid C, Soong SJ et al. Final version of the merican Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 21; 19: Dimberg LY, nderson CK, Camidge R et al. On the to successful cancer therapy? Predicting and counteracting resistance against -based therapeutics. Oncogene 212; 14: Dyer MJ, MacFarlane M, Cohen GM. arriers to effective -targeted therapy of malignancy. J Clin Oncol 27; 25: Hersey P, Zhang XD. How melanoma cells evade trail-induced apoptosis. Nat Rev Cancer 21; 12: reckenridge DG, Germain M, Mathai JP et al. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 23; 22: oyce M, Yuan J. Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ 26; 13: Liu H, Jiang CC, Lavis CJ et al. 2-Deoxy-D-glucose enhances -induced apoptosis in human melanoma cells through XP-1-mediated up-regulation of -R2. Mol Cancer 29; 8: Hitomi J, Katayama T, Eguchi, Y et al. Involvement of caspase-4 in endoplasmic retidulum stress-induced apoptosis and a beta-induced cell death. J Cell iol 24; 165: Morishima N, Nakanishi K, Takenouchi H et al. n endoplasmic reticulum stress-specific Caspase cascade in apoptosis. Cytochrome c-independent activation of Caspase-9 by Caspase-12. J iol Chem 22; 277: Nakagawa T, Zhu H, Morishima N et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2; 43:

表1.eps

表1.eps Vol.1 C ontents 1 2 cell-free EMBO J Proc. Natl. Acad. Sci. USA NatureEMBO J 3 RNA NatureEMBO J Nature EMBO J 4 5 HCV HCV HCV HCV RNA HCV in situ 6 7 8 Nat Struct Mol Biol J Biol Chem Nat Commun J Virol

More information

PL Prof. Jean Gruenberg Department of Biochemistry, University of Geneva A L1 L A 18

PL Prof. Jean Gruenberg Department of Biochemistry, University of Geneva A L1 L A 18 PL L1L2 Y1Y5 S1S4 SS1SS8 LS PL Prof. Jean Gruenberg Department of Biochemistry, University of Geneva 8 30 15001600 A L1 L2 8 30 14001500 A 18 19 8 31 13001400 A Y1 Hirata A and Nakamura H. Localization

More information

2

2 2 3 4 5 6 7 8 9 1 2 3 4 5 10 11 12 1 2 1 2 1 2 13 14 3 17 15 1 2 3 D Usefulness of Tc-99m MIBI SPECT in predicting multidrug resistance gene expression level in non-small cell lung cancer a preliminary

More information

ÿþ

ÿþ TNF ファミリー 腫瘍壊死因子 ( Tumor Necrosis Factor: TNF) は 固形がんに対して出血性の壊死を誘導する因子として発見されたサイトカインです TNF ファミリーには TNF-α リンフォトキシンα Fas リガンドや TRAIL などのアポトーシス誘導に関与するサイトカインのほか RANK リガンド OX40 リガンド APRIL など 20 種類近くに因子が同定されています

More information

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ 29 1 31 40 2014 31 Bisphosphonate related osteonecrosis of jaw; BRONJ 2008 4 2012 3 36 98 8 11 19 BRONJ 0 13 2 5 3 1 1 0 BP 4 15 10 5 α-streptococcus 0 BRONJ BRONJ BP I Paget 1 409-3898 1110 2014 1 27

More information

第79回_プログラム.indd

第79回_プログラム.indd Regulation of ghrelin signaling by a leptin-induced gene, negative regulatory element-binding protein, in the hypothalamic neurons. Phase I clinical trial using peptide vaccine for human vascular endothelial

More information

MAP MAP MAP MAPKKK /MAP MAPKK /MAP MAPK MAPK MAP Microtubule associated protein 2 MAP Dundee Sturgill MAP MAP ERK1 ERK2 MAP Nerve Growth Factor NGF MA

MAP MAP MAP MAPKKK /MAP MAPKK /MAP MAPK MAPK MAP Microtubule associated protein 2 MAP Dundee Sturgill MAP MAP ERK1 ERK2 MAP Nerve Growth Factor NGF MA 四 細胞生物学 八月 東京大学理学部生物化学科卒業 すけ 昭和二八年 東京大学大学院理学系研究科博士課程修了 介 昭和五一年 理学博士 えい 日本学術振興会奨励研究員 栄 東京大学理学部助手 だ 六月 京都大学ウイルス研究所教授 田 五月 京都大学大学院理学研究科教授 にし 五年 京都大学大学院生命科学研究科教授 現在に至る 西 平成 九年 京都大学大学院生命科学研究科長 平成二一年まで 受賞者 専攻学科目

More information

Untitled

Untitled 上原記念生命科学財団研究報告集, 24(2010) 152. 随意的な骨形成誘導を可能にする前骨芽細胞増殖促進, アポトーシス抑制メカニズムの解析 森幹士 Key words:proliferation,anti-apoptosis,signal crosstalk,osteoblast,osteosarcoma 滋賀医科大学医学部整形外科学講座 緒言著者らは, 骨形成型腫瘍は, 骨環境に働きかけることで腫瘍増大と骨形成とに適する環境を作り出しているとの仮説を立て,

More information

サイトメトリー12-1.indd

サイトメトリー12-1.indd Cell Growth Inhibition and Apoptosis in Cancer Cells Kazuki Omoteyama, Shoichi Inoue and Alaa-eldin Salah-eldin Department of Environmental Medicine and Informatics, Graduate School of Environmental Earth

More information

研究成果報告書

研究成果報告書 21 5 28 2007 2008 CARElk CARPXR CAR CAR EST cdna CAR CAR 10FCS 96 SW480 HepG2 anti-lamin A/C anti-phospho-histone H3 anti-cyclin D1 G1 anti-cyclin A S CAR lamin A/C CAR Fig. 1 Lamin A/C /G1 lamin A/C G1

More information

1. Ishida-Yamamoto A, Dera i son C, Bonnart C, B i toun E, Robinson R, O'Brien TJ,Wakamatsu K, Ohtsubo S, Takahashi H, Hashimoto Y, Dopping-Hepenstal PJ, McGrath JA, lizuka H, Richard G, Hovnanian A. LEKTI

More information

レントゲン X線

レントゲン X線 PET ( TIAN Mei ) PET 100 PET PET PET PET PET Positron Emission Tomography (PET) PET Positron Emission Tomography CT PET FDG Glucose and 18 F-FDG 18 F-FDGFDG CH3OH O CH3OH O OH OH OH OH OH OH OH 18 F *FDG

More information

J Life Sci Res 2014; 12: Osaka Prefecture University Journal of Life Science Research Online ISSN

J Life Sci Res 2014; 12: Osaka Prefecture University Journal of Life Science Research Online ISSN J Life Sci Res 2014; 12: 15-19 2014 Osaka Prefecture University Journal of Life Science Research Online ISSN 2186-5809 583-8555 3-7-30 577-8567 3-1-1 2014 9 11 2014 10 21 Exposure mild-level LED light

More information

ヒト悪性黒色腫における H 2 O 2 による 細胞内スーパーオキシド産生を介した 細胞死の増強効果の研究 日本大学大学院医学研究科博士課程 内科系皮膚科学専攻 栃木美寿紀 修了年 2014 年 指導教員落合豊子

ヒト悪性黒色腫における H 2 O 2 による 細胞内スーパーオキシド産生を介した 細胞死の増強効果の研究 日本大学大学院医学研究科博士課程 内科系皮膚科学専攻 栃木美寿紀 修了年 2014 年 指導教員落合豊子 ヒト悪性黒色腫における H 2 O 2 による 細胞内スーパーオキシド産生を介した 細胞死の増強効果の研究 日本大学大学院医学研究科博士課程 内科系皮膚科学専攻 栃木美寿紀 修了年 2014 年 指導教員落合豊子 ヒト悪性黒色腫における H 2 O 2 による 細胞内スーパーオキシド産生を介した 細胞死の増強効果の研究 日本大学大学院医学研究科博士課程 内科系皮膚科学専攻 栃木美寿紀 修了年 2014

More information

5698-5701. 5) Kadowaki T, Tobe K, Honda-Yamamoto R, Tamemoto H, Kaburagi Y, Momomura K, et al.: Signal transduction mechanism of insulin and insulin-like growth factor-1. Endocrine J 1996; 43: 33-41. 6)

More information

9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00

9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00 9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00 ポスターについて 1. ポスター 貼 付 用 の 展 示 ボードは 縦 180 横 90cm の 大 きさです 2. 演 題 名 発 表 者 名 所 属 を 明 記 したもの(20 70cm) をご 用 意 ください 実 際 使 用 できるスペースは 155

More information

CAR-T実施

CAR-T実施 Building a Clinical CAR-T Program - Jichi Medical University Experience l l l Anti-CD3/28 mabs & IL-2: 29% Anti-CD3/28 beads: 66% Retroviral: 41% Lentiviral: 54% T-Flasks: 22% Static Culture Bags: 35%

More information

第124回日本医学会シンポジウム

第124回日本医学会シンポジウム III γ γ γ α γ Molecular Mechanism of Insulin Resistance by Adipocytes TAKASHI KADOWAKI Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo Key words γ 110 124 TNFα FFA 1,2

More information

Database Center for Life Science Online Service

Database Center for Life Science Online Service Database Center for Life Science Online Service Database Center for Life Science Online Service Database Center for Life Science Online Service Database Center for Life Science Online Service SMN (Survival

More information

ミニレビュー

ミニレビュー Molecular mechanisms of the suppression of inflammation by thermal stress Ryosuke Takii Department of Biochemistry and Molecular Biology, Yamaguchi University Graduate School of Medicine, Ube 755-8505,

More information

研究成果報告書

研究成果報告書 21 4 25 peroxynitrite angiotensin II ETA MEK/ERK pathway endothelin-1 EDHF (EDHF) EDHF EDHF EDHF 2 [phosphodiesterase 3 (PDE3) cilostazol metformin thromboxane A2 ozagrel eicosapentaenoic acid (EPA) angiotensin

More information

11713_SciSig_vol14p

11713_SciSig_vol14p Science Signaling 日 本 語 版 ダイジェスト vol.14 http://www.sciencesignaling.org/ ScienceSignaling.org Science Signaling Science Signaling Science Signaling Editorial Guide Focus Issue:TOR シグナル 伝 達 2 つの Focus Issue:

More information

/‚“1/ŒxŒ{‚×›î’æ’¶

/‚“1/ŒxŒ{‚×›î’æ’¶ 60 1 pp.3-8 2010 1. H1N1 1) 2) 3) 4) ERATO 2009 H1N1 21 H1N1 HA PB2 2009 3 Pandemic H1N1 2009 WHO 6 11 21 2009 11 2010 4 21 H1N1 H1N1 2009 4 15 CDC 108-8639 4-6-1 TEL: 03-5449-5281 FAX: 03-5449-5408 E-mail:

More information

熊本大学学術リポジトリ Kumamoto University Repositor Title 炎症性腸疾患に対する HSF1 及び HSP70 の保護的役割 Author(s) 田中, 健一郎 Citation Issue date Type URL Thesis or Di

熊本大学学術リポジトリ Kumamoto University Repositor Title 炎症性腸疾患に対する HSF1 及び HSP70 の保護的役割 Author(s) 田中, 健一郎 Citation Issue date Type URL Thesis or Di 熊本大学学術リポジトリ Kumamoto University Repositor Title 炎症性腸疾患に対する HSF1 及び HSP70 の保護的役割 Author(s) 田中, 健一郎 Citation Issue date 2008-03-25 Type URL Thesis or Dissertation http://hdl.handle.net/2298/9448 Right 1

More information

body size no effect mechanical stress GH-IGF1 system + no effect? collagen production of fibroblasts + receptor + + Ia, Ib, II aldosterone renin angiotensin system Mechanical and Endocrinological

More information

NL10

NL10 Information September, 2006 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10 September, 2006 3 2006 4 Japanese Association for Molecular Target Therapy of Cancer News Letter

More information

untitled

untitled RYZA IL & FAT CHEMICAL C., LTD. SAKURA EXTRACT Ver.1.4MK Ver. 1.4MK 1) 1300 1929 1 Ver. 1.4MK Sakura 1-caffeoyl---D-glucopyranoside quercetin 3---D-glucopyranoside 1) :, 4, 11-22 (1995). 2 Ver. 1.4MK 3

More information

1 P2 P P3P4 P5P8 P9P10 P11 P12

1 P2 P P3P4 P5P8 P9P10 P11 P12 1 P2 P14 2 3 4 5 1 P3P4 P5P8 P9P10 P11 P12 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 & 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 1! 3 2 3! 4 4 3 5 6 I 7 8 P7 P7I P5 9 P5! 10 4!! 11 5 03-5220-8520

More information

Folia Pharmacol. Jpn mg/14 ml mg/ ml Genentech, Inc. Genentech HER human epidermal growth factor receptor type HER - HER HER HER HER

Folia Pharmacol. Jpn mg/14 ml mg/ ml Genentech, Inc. Genentech HER human epidermal growth factor receptor type HER - HER HER HER HER Folia Pharmacol. Jpn. 143 420 mg/14 ml 1 2 3 4 mg/ ml Genentech, Inc. Genentech HER human epidermal growth factor receptor type HER - HER HER HER HER HER KPL- HER BO HER CLEOPATRA HER HER 1. HER HER EGFR

More information

yakugaku-kot.ppt

yakugaku-kot.ppt 2009 Masaaki Kotera kot@kuicr.kyoto-u.ac.jp 2 I II / A () B1 () B2 B12 C () D A D () () () () DNA 5- http://www.genome.jp/kegg/pathway.html KEGG PATHWAY Database Xenobiotics biodegradation http://www.genome.jp/kegg/pathway.html

More information

Kazumitsu Ueda, [Department of Applied Life Science, Kyoto University Graduate School of Agriculture, Kitashirakawa, Sakyo-ku, Kyoto 606-01, Japan] Molecular Mechanisms for Drug Transport by MDR1/P-glycoprotein

More information

46 12 3 1 ATP ( ) ATP ~P 1~P hyd Gº 1 1 1950 ~P hyd Gº Hansia et al. Biophys Chem 119: 127, 2006 ~P hyd Gº 1? ATP hyd Gº ATP ATP ATP ~P ε ~P George [BBA 223: 1, 1970] ~P 2) hyd Gº 1. ph Mg 2+ 2. 1 2 2

More information

1) Asa, S. L., et al.: Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenoma, Arch. Pathol. Lab. Med., 108: 40 `43, 1984. 2) Chi, B. H. and Kim, R. C.:

More information

Sulfonylurea Receptors Pancreatic Type: SUR1 Cardiac Type: SUR2A Smooth Muscle Type: SUR2B Kir Channels uka-rp-1/kir6.1 BIR/Kir6.2 1) Ho K, et al : Cloning and expression of an inwardly rectifying ATP-regulated

More information

センシンレンのエタノール抽出液による白血病細胞株での抗腫瘍効果の検討

センシンレンのエタノール抽出液による白血病細胞株での抗腫瘍効果の検討 Evaluation of anti-tumor activity with the treatment of ethanol extract from Andrographis Paniculata in leukemic cell lines Hidehiko Akiyama 1), Kazuharu Suzuki 2), Toshiyuki Taniguchi 2) and Itsuro Katsuda

More information

-1 - -2 - -3 - -4 - -5 - -6 - -7 - -8 - -9 - - 10 - -11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - - 28 - - 29 - - 30 - - 31 - - 32

More information

研究成果報告書

研究成果報告書 系 レニン 1. Ito D, Ito O, Mori N, Suda C, Hao K, Cao P, Muroya Y, Takashima K, Shimokawa H, Kohzuki M. Exercise training upregulates nitric oxide synthases in the kidney of rats with chronic heart failure.

More information

北陸地域アイソトープ研究会誌第7号

北陸地域アイソトープ研究会誌第7号 IMRT Hyper-radiosensitivity and Increased radioresistance Radiation adaptive response Radiation-induced bystander effect 0.5 Gy hyper-radiosennsitivity HRS 0.5 Gy increased radioresistance IRR HRS IRR

More information

1_2.eps

1_2.eps 第32回 日本頭頸部癌学会ランチョンセミナー6 Pre-Meeting Abstract FDG-PET の頭頸部癌における臨床的有用性 司会 長 放射線治療センター長 講演 1 耳鼻咽喉科 部長 講演 2 PETセンター長 岡村 光英 先生 日時 2008年6月13日 金 12:00 13:00 会場 ハイアットリージェンシー東京 共催 第32回 日本頭頸部癌学会 日本メジフィジックス株式会社 136-0075

More information

; cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml Mφ 6 7, 8 9

; cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml Mφ 6 7, 8 9 32, 21-25, 2012 CASLE 1 1 80 26 6 5 4 cm 1 2 CEA 3 4 CEA 2 44 22 2 3 1.5 cm 22 1. 1 ; 6 5 4 cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml 0-40 5 Mφ 6 7, 8 9 23 6. ; 9. ; 7. ; 10. ; 8. 7 10 CK3 CK3 24 1,2 3 2 8% 4,5

More information

放射線ホルミシス太田成男

放射線ホルミシス太田成男 Key words: hormesis horme ( to excite) Radiation hormesis 1978 D 20! T.D. ( ), ( ) : (2011/08) 1,000 msv 3,000 400 (Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII-Phase 2 BEIR

More information

細胞死研究の最前線ネクロプトーシスshort

細胞死研究の最前線ネクロプトーシスshort 細胞死研究の最前線 制御されたネクローシス ( ネクロプトーシス ) 東邦大学医学部生化学講座中野裕康 Tumor necrosis factor(tnf) αは腫瘍壊死因子と日本語に訳されるが 皮肉なことに TNFαにより誘導されるネクローシスの分子メカニズムの大枠が解明されたのはごく最近のことである 長らくアポトーシスは計画的細胞死 ( プログラム細胞死 ) あるいは制御された細胞死と同義語のように扱われてきたのとは対照的に

More information

Title 骨量規定転写因子シュニュリ3の新規標的遺伝子同定と機能解析 Author(s) 石堂, 康弘 Citation Issue Date 2014-06-27 URL http://hdl.handle.net/10232/24125 http://ir.kagoshima-u.ac.jp adult (Schnurri, Shn)3/Hivep3 Runx2 Shn/Hivep Shn3

More information

_統合化推進プログラム_金久チーム_サイトビジット資料

_統合化推進プログラム_金久チーム_サイトビジット資料 ライフサイエンスデータベース統合推進事業統合化推進プログラム ゲノム 疾患 医薬品のネットワークデータベース実施状況 京都大学化学研究所 金久 實 2018 年 8 月 22 日サイトビジット資料 KEGG NETWORK とは NAR DB Issue 2017 KEGG: new perspectives on genomes, pathways, diseases and drugs From

More information

1) van Meer, G., Op den Kamp, J. A.: J. Cell. Biochem., 19, 193-2040982) 2) Gaffet, P., Bettache, N., Bienvenue, A.: Biochemistry, 34, 6762-6769(1995) 3) Sims, P. J., Wiedmer, T.: Thromb. Haemost., 86,

More information

2 251 Barrera, 1986; Barrera, e.g., Gottlieb, 1985 Wethington & Kessler 1986 r Cohen & Wills,

2 251 Barrera, 1986; Barrera, e.g., Gottlieb, 1985 Wethington & Kessler 1986 r Cohen & Wills, 2014 25 1 1 11 1 3,085 100 1 1988 e.g., 2000 3 e.g., 2005; 1999 100 1960 100 2012 2 6 23 1 98.2 1999 1999 3 65.3 1999 1996 1 21 e.g., 1999 3 1 2 251 Barrera, 1986; 1993 1 2 2001 3 2001 Barrera, 1981 1993

More information

NL11

NL11 information September, 2007 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11 September, 2007 3 2007 4 Japanese Association for Molecular Target Therapy of Cancer News Letter

More information

Figure 1 Mechanisms of blood coagulation and its regulation pathways. AT, antithrombin; HCII, heparin cofactor II; TFPI, tissue factor pathway inhibit

Figure 1 Mechanisms of blood coagulation and its regulation pathways. AT, antithrombin; HCII, heparin cofactor II; TFPI, tissue factor pathway inhibit Online publication October 3, 2011 総 説 特集 : 血栓止血, 凝固線溶 (1) 血栓形成機構 : 最近の知見 血液凝固機序 血栓形成と細胞機能に及ぼす凝固因子の作用機序 要 旨 : J Jpn Coll Angiol, 2011, 51: 287 292 Key words: atrial fibrillation, deep venous thrombosis,

More information

VENTANA PD-L1 SP142 Rabbit Monoclonal Antibody OptiView PD-L1 SP142

VENTANA PD-L1 SP142 Rabbit Monoclonal Antibody OptiView PD-L1 SP142 VENTANA PD-L1 SP142 Rabbit Monoclonal Antibody OptiView PD-L1 SP142 2 OptiView PD-L1 SP142 OptiView PD-L1 SP142 OptiView PD-L1 SP142 PD-L1 OptiView PD-L1 SP142 PD-L1 OptiView PD-L1 SP142 PD-L1 OptiView

More information

The Molecular Biology Society of Japan MBSJ NEWS 2013.11 No.106 http://www.mbsj.jp/ 2020 2020 7 2009 4 1 3 2011 1 3 1 2020 XLab 2 3 4 5 XLabExperiment, experience, exciting, expert Eva-Maria Neher 20

More information

untitled

untitled ORYZA CERAMIDE -PTPCDP8TP20CD -WSPWSP8 -LL0.8 -PCPC8PC20 -WSPCWSPC8 -LCLC0.8 Ver.13.0HS ORYZA CERAMIDE Ver.13.0HS 1. 2. 20 NMR 4 ( 1) 1 Ver.13.0HS HO CH 2 OH O O OH OH OH C CH CH H 2 NH C O R C H C H (CH

More information

C-1 210C f f f f f f f f f f f f f f f f f f f f r f f f f f f f f f f f f f R R

C-1 210C f f f f f f f f f f f f f f f f f f f f r f f f f f f f f f f f f f R R 4 5 ff f f f f f f f f f f f f ff ff ff r f ff ff ff ff ff ff R R 7 b b ï φφ φφ φφ φ φ φφ φφφφφφφφ φφφφ φφφφ ù û û Æ φ ñ ó ò ô ö õ φφ! b ü ú ù û ü ß μ f f f f f f f f f f b b b z x c n 9 f φ φ φ φ φ φ

More information

<95AA8E718CA4838C835E815B D862E696E6464>

<95AA8E718CA4838C835E815B D862E696E6464> T1r T1r1 T1r3 T1r2 T1r3 [1] T1r T1r 500 LBD 1 LBD T1rLBD [2] T1r T1r2a T1r3 LBD [3] T1r2a/T1r3 L- [4] T1r2a/T1r3LBD M~ M T1rLBD FRET FRET T1rLBD [3] 1 T1r 2 T1r2a/T1r3 X [3] 28 75 March 2017 T1rLBD imsaxst1r2a/t1r3lbd

More information

2 Gy-IGF'5 ng/ml

2 Gy-IGF'5 ng/ml 2 Gy-IGF'5 ng/ml CONCLUSION : The decrease in the number of differentiated cells and reduction in myotube formation induced by X'ray radiation of 2 Gy were inhibited by IGF-1. The X-ray irradiation at

More information

indd

indd Molecular Targeted Therapy for Lung Cancer from a Pharmaceutical Point of Viewe Naho SASAKI epidermal growth factor receptor tyrosine kinase inhibitor :EGFR-TKI vascular endothelial growth factor:vegf

More information

Tox

Tox CytoTox 96 Non-Radioactive Cytotoxicity Assay No. TB163J 2000 8 G1780 I. 2 II. 2 III. A. 4 B. CytoTox 96 Assay 4 IV. A. 5 B. 5 C. LDH 5 V. A. 7 B. 8 C. LDH 8 D. 9 VI. A. 11 B. 12 VII. 13 VIII. 14 IX. A.

More information

Fig. 2 Signal plane divided into cell of DWT Fig. 1 Schematic diagram for the monitoring system

Fig. 2 Signal plane divided into cell of DWT Fig. 1 Schematic diagram for the monitoring system Study of Health Monitoring of Vehicle Structure by Using Feature Extraction based on Discrete Wavelet Transform Akihisa TABATA *4, Yoshio AOKI, Kazutaka ANDO and Masataka KATO Department of Precision Machinery

More information

研究成果報告書(基金分)

研究成果報告書(基金分) The most remarkable characteristic of the mammalian neocortex is its layered structure. Because all, but only the mammalian species, have this layered structure in the telencephalon, it has been accepted

More information

油圧1.indd

油圧1.indd 4 2 ff f f f f f f f f f f f f ff ff ff r f ff ff ff ff ff ff R R 6 7 φφ φφ φφ φ φ φφ φφφφφφφφ φφφφ φφφφ φφ! φ f f f f f f f f f f 9 f φ φ φ φ φ φ φ φ φφ φφ φ φ φ φ SD f f f KK MM S SL VD W Y KK MM S SL

More information

研究成果報告書

研究成果報告書 500μm Before ATP After 10 Sikora J, Orlov SN, Furuya K, and Grygorczyk R (2015) Hemolysis is a primary and physiologically relevant ATP release mechanism in human. Blood 125: 1845 (Response to a letter)

More information

untitled

untitled ORYZA POLYAMINE ORYZA POLYAMINE -P -PC -LC 1. Ver.1.0 MM ver. 1.0MM 1) Roseeuw D.I. et al., Epidermal keratinocytes actively maintain their intracellular polyamine levels. Cell Tissue Kinet. 16, 493-504

More information

Doi: /electroph.61.9 Phos-tag SDS-PAGE MEK1 * SUMMARY MEK1, a chief component of the mitogen-activated protein

Doi: /electroph.61.9 Phos-tag SDS-PAGE MEK1 * SUMMARY MEK1, a chief component of the mitogen-activated protein 10 2017 61 9 Doi:10.2198/electroph.61.9 Phos-tag SDS-PAGE MEK1 * 2016 12 8 2017 1 10 SUMMARY MEK1, a chief component of the mitogen-activated protein kinase (MAPK) pathway, is phosphorylated during activation

More information

遺伝子ネットワーク解析

遺伝子ネットワーク解析 1.3 atsushi_doi@cell-innovator.com 6-10-1 I 2 http://www.cell-innovator.com 1 2 23andMe, GeneQuest, MYCODE DNA RNA DNA RNA DNA A, T, G, C RNA or = BioCyc (EcoCyc) KEGG Reactome WikiPathways TRANSPATH

More information

untitled

untitled 1) American College of Surgeons:Advanced Trauma Life Support Course Manual. American College of Surgeons 1997;103-112 24 2) American Society of Anesthesiologists Task Force:Practice guideline for blood

More information

腫瘍細胞のMDM2 特異的阻害剤Nutlin-3aに対する感受性とp53変異

腫瘍細胞のMDM2 特異的阻害剤Nutlin-3aに対する感受性とp53変異 NAOSITE: Nagasaki University's Ac Title 腫瘍細胞の MDM2 特異的阻害剤 Nutlin-3a に対する感受性と p5 Author(s) 長谷川, 寛雄 ; 山田, 恭暉 ; 上平, 憲 Citation 臨床化学, 39(3), pp.246-252; 2010 Issue Date 2010-07 URL http://hdl.handle.net/10069/26653

More information

小児感染免疫第25巻第2号

小児感染免疫第25巻第2号 2013 Vol. 25No. 2175 44 1972 28 1 Kikuchi s diseasekikuchifujmoto diseasehistiocytic necrotizing lymphadenitis Histiocytic necrotizing lymphadenitis, Kikuchi s disease, KikuchiFujimoto disease, subacute

More information

*4 Drug Delivery System original article Cytodegenerative and growth-inhibitory effects on LY-80 cells by methotrexate and 5-fluorouracil in combinati

*4 Drug Delivery System original article Cytodegenerative and growth-inhibitory effects on LY-80 cells by methotrexate and 5-fluorouracil in combinati *4 Drug Delivery System original article Cytodegenerative and growth-inhibitory effects on LY-80 cells by methotrexate and 5-fluorouracil in combination with angiotensin II induced hyperten sion chemotherapy

More information

No21Vol1.indd

No21Vol1.indd ( ): - PSA Shojiro Kano Head, Working Group of PSA Testing Standardization Committee (PSA) PSA PSA JCCLS PSA A PSA B PSA PSA Wang PSA FDA Hybritech Tandem-R PSA PSA PSA PSA - (ACT) - (AMG) ACT (PSA-ACT)

More information

Toshiya CHIHARA,M.D. and Takakazu SHIBATA, M.D.

Toshiya CHIHARA,M.D. and Takakazu SHIBATA, M.D. Toshiya CHIHARA,M.D. and Takakazu SHIBATA, M.D. Fig. 1 Clinical Appearrance on the Head and Face of Case 1 on the First Arrival Fig. 2 Clinical Appearrance on the Shoulder and Arm of Case 1 on the First

More information

上原記念生命科学財団研究報告集, 30 (2016)

上原記念生命科学財団研究報告集, 30 (2016) 上原記念生命科学財団研究報告集, 30 (2016) 147. オートファジーと細胞死を制御する癌抑制遺伝子の発見 難波卓司 高知大学教育研究部総合科学系複合領域科学部門 Key words: 小胞体ストレス, オートファジー,BAP31 緒言多くの固形癌や転移した癌は低栄養環境に置かれ 増殖を行うにはその環境に適応する必要がある そのため 癌細胞の低栄養環境への適応の阻害は新たな抗癌剤のターゲットとして有望であると考えられている

More information

PowerPoint プレゼンテーション

PowerPoint プレゼンテーション * ** 117,320 70,293 109,140 49,830 93,402 45,744 60,986 31,875 47,318 28,829 45,367 18,186 29,025 12,838 27,822 11,970 20,734 10,823 19,994 10,336 * 2007 ** 2011 65% 25% 9 DNA P53, ATM G1 S G2 G1 M 1

More information

橡皮膚機能と老化

橡皮膚機能と老化 1. Miyachi, Y. 1991. Reactive oxygen species as a factor of skin aging. Proceedings of international conference on skin aging. 73-84. 2. 4. Kligman, L. H., F. J. Akin, and A. M. Kligman. 1982. Prevention

More information

untitled

untitled 21 1 26 1 US6759035University of Southern California 1. A method for decreasing graft rejection of a solid organ by a recipient comprising: a) isolating peripheral blood mononuclear cells (PBMC) from a

More information

*Criteria 1) B-marker positive 2) Variability in nuclear size and shape 3) Giant cells and multinucleated cells

*Criteria 1) B-marker positive 2) Variability in nuclear size and shape 3) Giant cells and multinucleated cells *Criteria 1) B-marker positive 2) Variability in nuclear size and shape 3) Giant cells and multinucleated cells Abbreviation: LC=large cleaved nuclei, LNC=large non-cleaved nuclei, IMBL=immunoblastic nuclei,

More information

薬 理 学 教 室

薬 理 学 教 室 業績目録 ( 平成 22 年 ) (B-a) 英文総説 1) Fan C, Katsuyama M, Wei H, Xia Q, Liu W, Yabe-Nishimura C. Molecular Mechanisms Underlying PGF2alpha-induced Hypertrophy of Vascular Smooth Muscle Cells. Yakugaku Zasshi

More information

療養病床に勤務する看護職の職務関与の構造分析

療養病床に勤務する看護職の職務関与の構造分析 原著 :. JDS Job Diagnostic SurveyHackman & OldhamStamps, Herzberg Ⅰ. 諸言,, 10.,, 11 Ⅱ. 方法 1. 概念枠組みと質問紙の測定尺度 Hackman & Oldham Hackman & Oldham JDS 内発的動機づけ職務特性 技能多様性 タスク明確性 タスク重要性 自律性 職務からのフィードバック 他者からのフィードバック

More information

Microsoft Word - 森先生HP原稿

Microsoft Word - 森先生HP原稿 子宮体癌におけるエストロゲン関連受容体の意義と役割 森泰輔 1) 北脇城 2) 1) 京都府立医科大学大学院女性生涯医科学助教 2) 京都府立医科大学大学院女性生涯医科学教授 はじめに近年 子宮体癌の罹患率は急激に増加している 子宮体癌の危険因子とされる肥満 糖尿病 食事の欧米化 晩婚化 出産回数の低下に加え 高齢化などの社会的背景を考慮すると今後さらにその罹患率は増加すると予測される 子宮体癌の腫瘍学的特徴で最も重要な点はホルモン依存性であり

More information

p.3 BRICs p.11

p.3 BRICs p.11 31 GM VW 4 32 24 2011 58 2012.3.2 p.3 BRICs 2012 6 4 5 5 2012.5.10 p.11 33 2010.10.13 p.1 2010 238 2013 310 2012.5.25 p.3 2 5,000 7,500 2012.3.23 p.9 1 2. 1 1 2013.2.5 p.17 34 24 2012.1.1 p.7 2 2 1966

More information

Database Center for Life Science Online Service Virus infection and interferon system

Database Center for Life Science Online Service Virus infection and interferon system Virus infection and interferon system cing IFN-(3 ) /TICAM 1 (Toll-interleukin 1 receptor do main-containing adaptor molecule 1), TRAF6 (tumor necrosis factor receptor associated factor 6), TAB1 (TAK1-binding

More information

Establishment and progress of Sendai virus engineering 2) Schnell, M. J., Mebatsion, T., Conzelmann, K.-K.: EMBO J., 13,4195-4203(1994) 3) Kato, A. et al.: Genes Cells, 1, 569-579 (1996) 4) Nagai,

More information

評論・社会科学 85号(よこ)(P)/3.佐分

評論・社会科学 85号(よこ)(P)/3.佐分 well-being well-being well-being well-being QOL well-being satisfaction appraisal 69 well-being 2025 520 http : //www.mhlw.go.jp/ 2000 2004 2005 well-being 1 Walker 1996 ; Picot 1997 2003 2004 Zarit 1980

More information

細胞増殖測定細胞染色プロトコル

細胞増殖測定細胞染色プロトコル Cell Counting Kit Cell Counting Kit -8 3 Cell Counting Kit -F -Cellstain- -Cellstain- -Cellstain- Calcein-AM solution -Cellstain- CytoRed solution -Cellstain- BCECF-AM special packaging -Cellstain- -Cellstain-

More information

1 9 v.0.1 c (2016/10/07) Minoru Suzuki T µ 1 (7.108) f(e ) = 1 e β(e µ) 1 E 1 f(e ) (Bose-Einstein distribution function) *1 (8.1) (9.1)

1 9 v.0.1 c (2016/10/07) Minoru Suzuki T µ 1 (7.108) f(e ) = 1 e β(e µ) 1 E 1 f(e ) (Bose-Einstein distribution function) *1 (8.1) (9.1) 1 9 v..1 c (216/1/7) Minoru Suzuki 1 1 9.1 9.1.1 T µ 1 (7.18) f(e ) = 1 e β(e µ) 1 E 1 f(e ) (Bose-Einstein distribution function) *1 (8.1) (9.1) E E µ = E f(e ) E µ (9.1) µ (9.2) µ 1 e β(e µ) 1 f(e )

More information

fpj

fpj Folia Pharmacol. Jpn. 147 創 薬 シリーズ (8) 創薬研究の新潮流 2 高橋信明, 丹羽倫平, 中野了輔, 冨塚一磨 要約 : ADCC Potelligent 1. 抗体の構造と機能 G immunoglobulin G IgG IgG N VL CL VH CH CH CH CH CH complementarity determining region CDR CDR

More information

37-4.indd

37-4.indd ISSN 0916-3328 東京大学アイソトープ総合センター VOL. 37 NO. 4 2007. 3. 26 アイソトープ総合センターの将来展望 40 18 18 20 3 800 1/3 1300 14 18 20 3 19 2 生きた細胞内の分子過程を 時間 空間計測する蛍光プローブの開発 1. はじめに Fura-2 Fura-2 198 1, 2 3, 4 2. 生体脂質分子の機能とその分析

More information

Tomohiro Terada, Ken-ichi Inui, Peptide transporter family situ 1) Matthews, D.M. : Physiol. Rev., 55, 537-608(1975) 2) Ganapathy, V.. Leibach, F.H.: Am. J. Physiol. Gastro intest. Liver Physiol.,

More information

Correlation between molecular evolution of P450s and evolution of plant secondary metabolism Masaharu Mizutani E-mail : mizutani@scl.kyoto-u.ac.jp URL : http://biofun.kuicr.kyoto-u.ac.jp/index-j.html 13)

More information

日本消化器外科学会雑誌第29巻第9号

日本消化器外科学会雑誌第29巻第9号 Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe

More information

VENTANA ALK D5F3 Rabbit Monoclonal Antibody OptiView ALK D5F3

VENTANA ALK D5F3 Rabbit Monoclonal Antibody OptiView ALK D5F3 VENTANA ALK D5F3 Rabbit Monoclonal Antibody OptiView ALK D5F3 2 OptiView ALK D5F3 11 10 79.3%31% 18% 80 85NSCLC 40% 1,2 1 1018 ALK ALK 2 ALK 3 5% ALK EML4 EML4-ALK Coild-Coil ALK ALK 3,4,5 2 6 EGFR 50%

More information

() ( 2 1)90 (2010) ( 1) QIAGEN DNeasy Blood & Tissue Handbook FAVORGEN Tissue Genomic DNA Extract

() ( 2 1)90 (2010) ( 1) QIAGEN DNeasy Blood & Tissue Handbook FAVORGEN Tissue Genomic DNA Extract 2012 (Sekiya et al 2012) ( ) ( 1) 1 1. 2010 2012 2013 2014 6 () 2014 8 29 481 ( 2 1)90 (2010) 461 20 5 5 35 ( 1) QIAGEN DNeasy Blood & Tissue Handbook FAVORGEN Tissue Genomic DNA Extraction Mini Kit DNA

More information

Perrett et al.,,,, Fig.,, E I, 76

Perrett et al.,,,, Fig.,, E I, 76 Attempting to Express Strong-impression Face Images from Features of Spatial Frequency: A Consideration of Billiken Statues and Bijin-ga Sakura Torii abstract It is difficult to express the psychological

More information

Generation of neural cells from embryonic stem cells Database Center for Life Science Online Service Takuya Yohei Okada Takahito Hideyuki Shimazaki Yo

Generation of neural cells from embryonic stem cells Database Center for Life Science Online Service Takuya Yohei Okada Takahito Hideyuki Shimazaki Yo Generation of neural cells from embryonic stem cells Takuya Yohei Okada Takahito Hideyuki Shimazaki Yoshizaki* Okano McLean Hospital/Harvard University Udall Parkinson's Disease Research Center of Excellence

More information

14UNAIDS HIV 39% i 9 ii9iii UNAIDS x.9x.9x1= ?? UNAIDS % 77%8% 44.7x.77x.8x1=

14UNAIDS HIV 39% i 9 ii9iii UNAIDS x.9x.9x1= ?? UNAIDS % 77%8% 44.7x.77x.8x1= DeCEMBER, 17 No.34 HIV 169-73 1-1-1-13TEL 3-5937-4413:3 19:3 FAX 3-5937-443E-mail info@janpplus.jp http://janpplus.jp/!9-9-9!... 1-3 POSITIVE HIV/AIDS UNAIDS!... 4-5 JaNP+HIV Cafe Bar an opportunity...

More information

計算機生命科学の基礎II_

計算機生命科学の基礎II_ Ⅱ 1.4 atsushi_doi@cell-innovator.com 812-8582 3-1-1 8 806 http://www.cell-innovator.com BioGPS Connectivity Map The Cancer Genome Atlas (TCGA); cbioportal GO DAVID, GSEA WCGNA BioGPS http://biogps.org/

More information

: / FDA HBsAg HIV 1/2 HCV : QMS : 3.5% IgM () 1.0% H317 - H334 - : : :: : QMS Everolimus : 6.4% (II) H400 - H % SDS QMS EDTA (K 3 ) EDTA (K 2 )

: / FDA HBsAg HIV 1/2 HCV : QMS : 3.5% IgM () 1.0% H317 - H334 - : : :: : QMS Everolimus : 6.4% (II) H400 - H % SDS QMS EDTA (K 3 ) EDTA (K 2 ) QMS (EVER) 0373852 (QMS) QMS QMS X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X

More information

Review Yoshihiro Yoneda, Soo Jae Lee, E-mail : yyoneda@anat3.med.osaka-u. ac.jp http: //www.anat3.med.osaka-u.ac.jp/ Molecular basis of importin g revealed by crystal structures 2) Yoneda, Y. : Genes

More information

D., Nicola, N. A., Hilton, D. J.: Nature, 387, 917-921 (1997) 12) Alexander, W. S. : Nat. Rev. Immunol., 2,410-416 (2002) 13) Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., Shuai, K. : Science,

More information